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Abstract 
DNA interactions of anticancer mononuclear Cu
2+
,Co
2+
,Zn
2+
, and Ni
2+
 complexes with the biologically active 
ligand clotrimazole (clotri) are reported. To fully characterize DNA binding modes for these complexes of 
the formulae [M(clotri)2Cl2]·nH2O (1–4), [M(clotri)2Br2]·nH2O (5, 6), [M(clotri)3NO3]NO3·nH2O (9), and 
[M(clotri)3(NO3)2] (10), circular dichroism (CD) and linear dichroism (LD) spectroscopy, UV melting 
experiments, atomic force microscopy (AFM) and ethidium bromide (EtBr) displacement methods were 
used. Results indicate mixed electrostatic interactions, possibly through groove binding, that result in 
accretion and coiling of DNA. Electrochemical studies indicate that the Cu
2+
 complex 9 readily reduces to 
the reactive-oxygen-species-generating Cu
+
, which oxidatively damages DNA. There is a subtle correlation 
between log P values, calculated electrostatic potentials, and cytotoxicity of the complexes. The extent of 
cell-nucleus DNA-metal adduct formation in the HeLa cervix-uterine carcinoma cell line does not 
necessarily correlate with cytotoxicity, indicating that the nature of DNA lesions may be crucial to activity. 
  
Introduction 
Platinum complexes are the most widely used metal-based anticancer drugs;
1,2
 however, new generations of 
agents that also possess anticancer activity but which can widen the spectrum of treatable cancers, reduce 
toxic side effects, and overcome resistance are needed. Multi-targeted drugs have appeared in treatment 
regimens as a response to this medical need given their ability to affect multiple separate biotargets.3 One 
approach to developing such drugs is the use of coordination compounds bearing bioactive ligands. Some of 
the advantages of using the aforementioned metal complexes include their capacity to exhibit an extensive 
range of coordination numbers and geometries, thermodynamic/kinetic preferences for ligand atoms, and in 
some cases, redox activity. These properties can all exert a critical influence on the biological activity and 
corresponding mechanisms of action.
4,5
 For example, some studies have shown that some metal ions generate 
reactive-oxygen-species (ROS),
6
 which although being an inevitable byproduct of cellular respiration, can 
result in cellular and subcellular oxidative stress and in an altered homeostasis state. 
In this respect, metal complexes are promising as a new generation of anticancer drugs for effective oxidant 
therapy; their anticancer activity may involve direct oxidative DNA-damage
7–9
 and/or interference in the 
redox signaling pathways in cancer cells by novel mechanisms.
10–12
 In particular, distortions of the DNA 
structure induced by metal-based anticancer agents often correlate with anticancer activity.
13–15
 Hence, it is of 
great importance to understand in detail the DNA binding properties of novel metal complexes and their 
possible relationship to cytotoxicity in tumor cells since this may provide grounds for establishing new 
structure-pharmacological activity relationships. In the studies presented herein, we demonstrate that the 
antitumor mechanism of mononuclear Cu
2+
,Co
2+
, Zn
2+
, and Ni
2+
 complexes of the biologically active ligand 
clotrimazole (clotri) of the forms [M(clotri)2Cl2]·nH2O (1–4), [M(clotri)2Br2]·nH2O (5, 6), and 
[M(clotri)3NO3]NO3·nH2O (9, 11) and [M(clotri)3(NO3)2] (10) previously studied by us,
17
 involves not only 
oxidative DNA damage with generation of ROS but also specific DNA interactions. 
 
Fig. 1 General structures of the Cu
II
, Co
II
, Zn
II
, and Ni
II
 complexes of clotrimazole (clotri) studied in this work. 
Materials and methods 
Materials 
The metal complexes were synthesized following previously described methods
16
 and have been formerly 
reported by us.
17
 Ethidium bromide (EtBr), calf thymus DNA (ct-DNA) and all the other chemicals and 
solvents were purchased from Sigma Aldrich and used without further purification. Synthetic B-DNA 
analogues were purchased from Amersham Bioscience. 
Inductively coupled plasma mass spectrometry 
The inductively coupled plasma mass spectrometry (ICP-MS) data where acquired on an Aurora M90 Bruker 
equipment. The samples were digested on a CEM MDS 2000 microwave oven using 1 mL of ultrapure 
HNO3. Then, 10 mL of distilled and deionized water were added. The high-purity standards used were Cat 
#QCS-26 Batch # 1223440. The Blood App. Note B1-9 (App Manual CEM, Solution to sample problems 
CEM) was used. 
Cell culture 
HeLa (cervix-uterine) human carcinoma cell line was acquired from ATCC (American Tissue Culture 
Collection) and maintained in incubation at 310 K and 5% CO2 with RPMI (GIBCO, Invitrogen) 
supplemented with 10% BFS (GIBCO, Invitrogen), 1% L-glutamine and 1% penicillin/streptomycin. 
Experiments were performed with cells within at least 5 passages from each other. All cells were split when 
around 80–95% confluence was reached using 0.25% trypsin/EDTA. 
DNA-metal adduct formation 
HeLa (cervix-uterine) human carcinoma cells were plated at a 3×10
6
 cells mL
−1
 in two T-25 culture flasks 
each, provided with 5 mL of RPMI medium (GIBCO, Invitrogen) supplemented with 10% BFS (GIBCO, 
Invitrogen), 1% L-glutamine and 1% penicillin/streptomycin and allowed to attach at 310 K for 24 h. Next, 
the attached cells were released from their corresponding flasks with 2 mL trypsin-EDTA, the two 
suspensions put together and centrifuged at 1500g for 5 min. The pellet was then re-suspended in 1 mL of 
supplemented RPMI medium. The cells were counted and 5 × 10
6
 cells mL
−1
 were transferred into a 
microcentrifuge tube and centrifuged for 5 min at 1500g; the culture media was then completely removed 
and discarded. The pellet was then treated for DNA extraction using the Mammalian Genomic DNA 
Miniprep kit (G1N10, Sigma-Aldrich) following the manufacturer’s procedure. All samples were stored at 
253 K until ICP-MS analysis for metal content. 
Determination of partition coefficient, log P 
Octanol-saturated water (OSW) and water-saturated octanol (WSO) were prepared using analytical grade 
octanol (Sigma) and 0.3 M aqueous NaCl, NaBr, or NaNO3 solutions. Aliquots of stock solutions of the 
corresponding metal complexes in OSW were added to equal volumes of WSO and mixed for 4 h after 
partition. The aqueous and octanol layers were carefully separated into test tubes for metal analysis. Aqueous 
samples before and after partitioning were diluted with 2–4% HNO3 to the appropriate range for analysis by 
ICP-MS calibrated with aqueous standards (Cu
2+
, Co
2+
, Ni
2+
, Zn
2+
 100.00 ± 0.5 μgmL−1). These procedures 
were carried out at ambient temperature. Partition coefficients of M = Cu2+, Co2+, Ni2+, Zn2+ complexes were 
calculated using the equation log Poct = log([M]oct/[M]aq.). 
UV-Vis absorption spectroscopy 
UV-Vis spectra were recorded using a Jasco V-660 spectrometer. Circular and linear Dichroism (CD, and 
LD, respectively) spectra were recorded using a Jasco J-720 spectropolarimeter adapted for LD 
spectroscopy. All UV-Vis and CD measurements were collected in 1 cm pathlength quartz cuvettes (Starna 
UK). The LD measurements were performed using a quartz capillary LD Couette flow cell built by Crystal 
Precision Optics spinning at 3000 RPM.
18,19
 CD and LD spectra were measured over the desired wavelength 
range using a bandwidth of 2 nm, a data pitch of 0.2 nm, scanning speed of 100 nm min
−1
, response time of 1 
s and 2 (LD) or 4 (CD) accumulations. Baseline spectra of an appropriate buffer were recorded for CD. 
Baseline spectra for each of the LD samples were recorded with spinning turned off. All measurements were 
carried out at ambient temperature. 
DNA interactions 
Stock solutions. All solutions of ct-DNA were prepared by dilution of 3 mM (ca. 2 mg mL
−1
) stock solution 
in appropriate buffers, the exact concentrations were established using absorbance at 257 nm for ct-DNA (ε = 
6600 dm
3
mol
−1
cm
−1
), 254 nm for poly(dG-dC)2 (ε = 8400 dm
3
mol
−1
cm
−1
) and 262 nm for poly(dA-dT)2 (ε = 
6600 dm
3
mol
−1
cm
−1
).
20–22
 Approximately 1 mM stock solutions of complexes 1–5 were prepared in 
acetonitrile, the exact concentrations were calculated assuming molecular formulas and solvents of 
crystallization published previously.
17 
DNA melting. The stability of DNA in the presence of the metal complexes was monitored by measuring the 
absorbance at 260 nm as a function of temperature using the following parameters: bandwidth 2 nm, average 
time 10 s, heating rate 0.4 °C min
−1
. The experiments were run simultaneously in six masked 1 cm 
pathlength cuvettes of 1.2 mL volume using a Peltier controlled 6-sample changer in a Jasco V-660 
spectrometer. Tm (melting temperature) was calculated within the thermal heating program by applying a 
first derivative calculation. The concentration of ct-DNA was 7.5 × 10
−5
 M (per base) and buffer conditions 
were 10 mM Tris buffer (pH 7.0) and 1 mM EDTA in 50% acetonitrile. 
Ethidium bromide (EtBr) displacement assay 
Fluorescence measurements were performed at ambient temperature on a Jasco FP-6500 
spectrofluorophotometer using a 0.5 cm path length quartz cell. The DNA–EtBr complexes were excited at 
546 nm and the fluorescence was measured at 585 nm. Aliquots of a 1 mM stock solution of the compound 
in acetonitrile were added to a solution of EtBr and DNA (10 mM Tris pH 7.0, 1 mM EDTA, 1.3 μM EtBr, 
and 3.9 mM DNA in 10% acetonitrile). Concentrations of DNA and EtBr were kept constant by addition of 
an equal volume of EtBr or DNA solution at double the concentration. The fluorescence was measured after 
each addition until the signal was reduced by 50%. 
Circular dichroism (CD) titrations 
Starting solutions of 50 μM DNA in 1 mM Tris (pH 7.0), 0.1 mM EDTA, and 50% acetonitrile buffer were 
titrated with 0.1 and 1 mM stock solutions of the clotri metal complexes in acetonitrile. Concentrations of 
DNA and acetonitrile were kept constant throughout the titration by addition of an equal volume of 100 μM 
DNA solution. Concentration of the compound was increased from 0 to 50 μM. 
Linear dichroism (LD) titrations 
Due to the small volume of sample used in a typical experiment (60 μL) each sample in the titration series 
was prepared separately. All solutions were prepared in 10 mM Tris (pH 7.0), 1 mM EDTA, 50% acetonitrile 
buffer. The ct-DNA concentration was kept constant throughout the experiment at 100 μM, and the 
compound concentration was increased from 0 to 100 μM. Acetonitrile concentration was kept constant at 
50%. 
Electrochemistry 
Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) experiments were conducted with a CH 
Electrochemical Analyzer (CH Instruments, Inc.) in dry, degassed acetonitrile (or dichloromethane) with 
tetra-n-butylammonium hexafluorophosphate (100 mM) as a supporting electrolyte. The final concentrations 
of all compounds were 1 mM, with a final volume of 5 mL. All samples were degassed for 10 min with N2 
before each experiment. CV experiments were conducted with a scan rate of 100 mV s
−1
, and all figures 
show the overlay of the second and third scans. DPV experiments were conducted on all samples (some data 
not shown) and confirmed all waves observed in the cyclic voltammograms. Due to limited solubility, some 
of the compounds precipitated slightly towards the end of the electrochemical measurements in all solvents. 
All voltammograms were reproducible even when precipitation occurred. A pulse amplitude of 0.020 V and 
a pulse width of 0.050 were used for all DPV experiments, in conjunction with a sample width of 0.020 and a 
pulse period of 0.100. Samples of each complex were cycled between −1.6 V and 1.6 V using a glassy 
carbon working electrode, a Pt counter electrode, and a Ag/AgCl (+0.197 V vs. NHE)
23
 reference electrode. 
All experiments were externally referenced to ferrocene (0.593 V vs. Ag/AgCl).
24
 
DNA damage gel electrophoresis 
Deionized water, MOPS buffer (10 mM, pH 7.39), NaCl (130 mM), ethanol (10 mM), ascorbate (1.25 
equivalents per Cu
II
 ion; 7.5–62.5 µM), and the indicated concentrations of the Cu2+ complex (1–50 µM) in 
water were combined in a microcentrifuge tube and allowed to stand for 5 min at ambient temperature. 
Plasmid DNA (pBSSK; 0.1 pmol in 130 mmol NaCl solution) was then added to the reaction mixture and 
allowed to stand for 5 min at ambient temperature. Hydrogen peroxide (50 μM) was added and allowed to 
react at ambient temperature for 30 min, and then EDTA (50 μM) was added to quench the reaction. All 
given concentrations are final concentrations in a 10 μL volume. Samples were loaded into a 1% agarose gel 
in TAE running buffer; and damaged and undamaged plasmid DNA were separated by electrophoresis (140 
V for 30 min). Gels were then stained using EtBr and imaged under UV light. The amounts of nicked 
(damaged) and circular (undamaged) DNA were quantified using UViProMW (Jencons Scientific Inc., 
2007). The intensity of the circular plasmid band was multiplied by 1.24, due to the different binding abilities 
of EtBr to supercoiled and nicked plasmid DNA.
25,26
 
Atomic force microscopy (AFM) imaging 
Mica was purchased from Agar Scientific and was freshly cleaved before use using Sellotape. AFM images 
were recorded in tapping mode on Veeco Multimode V using Bruker FMV silicon probes (average resonant 
frequency 75 kHz, nominal spring constant 2.8 N m
−1
). Recorded images were processed using WSxM 
software.
27
 pUC19 plasmid was purchased from New England Biolabs, Hind III enzyme was purchased from 
Invitrogen. pUC19 Plasmid DNA (2686 bp) was linearized using Hind III enzyme following the 
recommended manufacturer procedure. The reaction mixture was purified using QIAprep Spin Miniprep Kit 
following the manufacturer procedure. The concentration of the obtained linear DNA was determined using 
absorbance at 260 nm. Solutions of linearized plasmid DNA (11 μM) with appropriate concentrations of the 
compound in 5 mM MgCl2/2.5% acetonitrile were prepared and left to equilibrate for 20 min at ambient 
temperature. 1 μL of the solution was then deposited for 10 min on a freshly cleaved surface of mica. The 
mica surface was subsequently washed for about 2 to 3 s with a jet of deionized water from a wash bottle and 
dried under a stream of nitrogen. 
Computational details 
Calculations on complexes 1–7 were performed with the Gaussian 09 program,28 employing the DFT method 
with the PBE0 functional.
29
 The LanL2DZ effective core potential30 was used for the Cu, Co, Zn and Ni 
atoms and the 6-31G** basis set
31
 was used for all other atoms. Geometry optimizations were performed 
using the PCM method
32
 and water as solvent. The nature of the stationary points was confirmed by normal 
mode analysis. Electrostatic potential surfaces (EPS) are shown both in space and mapped on electron 
density (isovalue 0.001) of the molecules. The electrostatic potential is represented with a color scale going 
from red (−0.1 a.u.) to blue (0.1 a.u.). 
  
Table 1 Selected calculated bond distances (Å) and angles (°) for complexes 1–7 
Bond distances (Å) (1) M = Cu2+ (2) M = Co2+ (3) M = Zn2+ (3) X-raya (4) M = Ni2+ 
M–Cl(1) 2.348(2) 2.323(8) 2.331(8) 2.210(6) 2.331(9) 
M–Cl(2) 2.340(0) 2.339(0) 2.357(3) 2.222(9) 2.329(6) 
M–N(1) 1.988(2) 2.048(1) 2.112(7) 2.043(7) 2.021(8) 
M–N(2) 1.986(9) 2.050(4) 2.114(4) 2.060(1) 2.021(8) 
Bond angles (°)      
Cl(1)–M–Cl(2) 142.5(8) 118.4(4) 126.8(6) 114.5(6) 146.2(8) 
Cl(1)–M–N(1) 94.1(9) 109.7(3) 109.8(5) 108.9(0) 100.6(1) 
Cl(1)–M–N(2) 94.6(5) 109.3(8) 107.6(4) 115.8(3) 100.7(8) 
Cl(2)–M–N(1) 94.6(9) 103.2(5) 102.5(7) 113.4(5) 101.2(0) 
Cl(2)–M–N(2) 93.7(7) 106.2(8) 104.2(4) 103.8(0) 101.0(3) 
N(1)–M–N(2) 152.7(8) 109.3(8) 103.3(2) 99.3(7) 98.5(5) 
Bond distances (Å) (5) M = Cu2+ (6) M = Co2+ (7) M = Zn2+ (7) X-raya  
M–Br(1) 2.475(4) 2.44751 2.471(6) 2.343(2)  
M–Br(2) 2.464(6) 2.45589 2.483(6) 2.361(1)  
M–N(1) 1.989(1) 2.04538 2.110(0) 2.036(7)  
M–N(2) 1.989(0) 2.04945 2.105(6) 2.039(1)  
Bond angles (°)      
Br(1)–M–Br(2) 137.4(4) 116.4(2) 126.0(6) 112.7(5)  
Br(1)–M–N(1) 95.7(2) 110.0(0) 107.7(2) 103.6(7)  
Br(1)–M–N(2) 95.7(3) 105.0(9) 104.7(8) 114.4(1)  
Br(2)–M–N(1) 95.0(0) 104.3(6) 103.7(0) 117.3(2)  
Br(2)–M–N(2) 94.9(8) 110.5(7) 106.0(9) 108.5(4)  
N(1)–M–N(2) 150.1(8) 110.4(4) 107.3(9) 99.6(3)  
a From reference 17. 
Results and discussion 
Structural properties of complexes 1–7 
To characterize the structural features of the clotri derivatives investigated in this work (Fig. 1), Density 
Functional Theory (DFT) geometry optimization calculations on complexes 1–7 were performed at the 
PBE0/LanL2DZ/6-31G** level
29–31
 using the PCM
32
 method for including solvent (water) effects. Details are 
summarized in Table 1. In the case of 3 and 7, their X-ray structures were previously solved
17
 and the 
calculated geometries display a good agreement with them, although bond distances and angles are 
somewhat overestimated by calculations as demonstrated previously for other systems.
33
 Cu
2+
 and Co
2+
 
derivatives were optimized as doublets and quartets respectively, while Zn
2+
 and Ni
2+
 were optimized as 
closed-shell complexes.
34
 Complexes 1–7 adopt a pseudo-tetrahedral coordination environment with both 
chlorido and bromido ligands in a trans-like geometry. This conformation was found to be the most stable 
compared to the cis-like structure (ΔE = 3.06–7.40 kJ mol−1). In complexes 1–4, M–Cl bond distances are in 
the range of 2.357–2.323 Å and are very similar to each other despite the differences in the central metal 
ions. An analogous trend was observed for the M–Br bonds in complexes 5–7, although at slightly larger 
values as expected. M–N(clotri) distances are comparable for all complexes, and the Cu2+ derivatives 1 and 5 
have the smallest values. The electrostatic potential surfaces (EPS; Fig. 2 and S1†) show that complexes 1–4 
and 5–7 have a similar charge distribution. 
 
Fig. 2 Electrostatic Potential Surfaces (EPS) for complexes 1–4 shown in both space and mapped on the electron 
density (isovalue 0.001) of molecules. The electrostatic potential is represented with a color scale going from red (−0.1 
au) to blue (0.1 au). 
Partition coefficient (log P values) 
It is known that the ability of a given drug to permeate biological membranes depends strongly on its 
lipophilicity,
35
 which is commonly experimentally determined by the partition coefficient of the compound in 
n-octanol/water (Po/w).
36
 Lipophilicity has been shown to affect absorption, transmembrane transport by 
means of passive diffusion reflecting the relative solubility of the drug in lipid-like (i.e. lipid bilayers of a 
cell membrane) and aqueous (the fluid in and out of cells) environments, bioavailability, cellular drug 
accumulation, hydrophobic drug–receptor interactions, metabolism, pharmacological activity, and toxicity of 
molecules.
37
 It has been previously reported that reduced uptake, resulting from either increased efflux or 
reduced influx, contributes to the acquired cisplatin resistance of tumors.
38–40
 In general terms, for an 
effective anticancer drug to initiate cell death, it must reach all viable cells in a tumor and be retained in 
sufficient concentrations on a relevant time scale. The partition coefficient (log P) values for the Cu2+, Co2+, 
Zn
2+
, and Ni
2+
 clotri complexes are shown in Table 2. The values that range from −2.09 to −0.27 do not 
necessarily correlate with cytotoxicity, and are significantly higher than that of cisplatin (−2.30).41 
Table 2 The log P and IC50 values for complexes 1‒4, 6, 8 and 9 log P values are the mean of two independent 
experiments and are expressed as mean ± SD 
  log P IC50 (μM) 
 Compound Mean SD HeLa 
(1) [Cu(clotri)2Cl2]·5H2O ‒0.62 0.02 6.8 
(2) [Co(clotri)2Cl2] ‒0.43 0.02 7.0 
(3) [Zn(clotri)2Cl2] ‒0.27 0.09 7.1 
(4) [Ni(clotri)2Cl2]·H2O ‒1.95 0.17 8.1 
(6) [Co(clotri)2Br2] ‒1.14 0.10 20.6 
(8) [Ni(clotri)3Br2] ‒2.09 0.06 13.6 
(9) [Cu(clotri)3NO3]NO3·2H2O  ‒0.28 0.05 3.5 
 Clotrimazole 5.44 0.51 12.4 
 Cisplatin ‒2.30  5.2 
DNA melting 
Due to the low solubility of some of these compounds in buffer solutions, most of the samples used in the 
measurements contained a significant fraction of acetonitrile (up to 50%). We have, however, shown 
previously that even high acetonitrile contents (≤60%) do not noticeably alter the structure and activity of B-
DNA.
42
 DNA melting temperature (Tm), defined as the temperature at which half of the DNA double strands 
are unwound into single strands, is an effective measure of thermal stability of DNA and DNA adducts.43 
DNA is believed to be a binding target for the clotrimazole metal complexes studied here, and this binding 
may result in the observed cytotoxicity.
17
 To determine if binding of these clotri complexes affects the 
stability of DNA structure, the melting temperatures of ct-DNA in the absence and presence of different 
concentrations of the metal compounds 1–3 and 9–10 as representative examples, were determined. The 
results obtained are summarized in Fig. 3. All compounds affect only very small changes on the thermal 
stability of DNA, near the detection limits of the instrument, as evidenced by the error bars. At all tested 
concentrations, compounds 1 and 10 show no effect on thermal stability of DNA, whereas compounds 2, 3 
and 9 lower the melting temperature of ct-DNA by approximately 0.5 °C. In all the cases, there is no 
significant change in melting temperature as the concentration of the compound is increased. These results 
suggest that DNA binding, if any, is quite weak and it does not significantly affect its thermal stability. Thus, 
weak electrostatic forces may be pointed as the main mechanism of interaction. 
 
 
Fig. 3 Effects of clotri complexes 1–3, 9 and 10 on thermal 
stability of ct-DNA at 20 : 1, 10 : 1 and 5 : 1 (DNA bp : 
compound) ratios. 
Fig. 4 Ethidium bromide displacement titration of ct-DNA 
with 1. The inset shows decreasing fluorescence at 585 
nm. See weak shoulder at 620 nm for higher 
concentrations of 1, due to intrinsic florescence of this 
compound. 
Ethidium bromide (EtBr) competition assay 
Ethidium bromide displacement experiments allow quantification of binding constants for DNA-binding 
compounds in relation to that of EtBr.
44
 EtBr is a known intercalator, binding between the stacked base pairs 
of the DNA with its long axis parallel to the long axis of the base pairs).
45
 Upon DNA binding, EtBr exhibits 
strong fluorescence that can be used to monitor the binding process. To extract more information about the 
DNA-binding of the selected clotri metal complexes and the possible sequence specificity, three different B-
DNA analogs, including ct-DNA, poly(dA-aT)2, and poly(dG-dC)2, were used. A typical titration curve is 
shown in Fig. 4 for complex [Cu(clotri)2Cl2]·5H2O (1), the inset shows decreasing intensity of EtBr 
fluorescence at 585 nm. The apparent binding constants (Kapp) were calculated using formula:           
     
 
     [    ]
 where c is the concentration of the compound at 50% observed reduction in fluorescence, 
[EtBr] is the concentration of ethidium bromide and KEtBr is known (KEtBr = 1×10
7
 M
−1
 for ct-DNA, 9.5 × 
10
6
 M
−1
 for poly(dA-dT)2 and 9.9 × 10
6
 M
−1
 for poly(dG-dC)2).
44
 The calculated Kapp values for compounds 
1–3 and 9–10 are shown in Table 3. For ct-DNA, compounds 1–3 show very similar Kapp values of 
approximately 4.8 × 10
4
 M
−1
. Similarly, compounds 9 and 10 show similar Kapp values approximately 1.5 
times higher (ca. 6.5 × 10
4
 M
−1
). For comparison, the binding constant (Kapp) of EtBr under the same 
conditions is on the order of 10
6
 M
−1
.
46
 Excellent agreement between the three values obtained for the bis-
ligand compounds and the two higher values obtained for tris-ligand complexes suggests that DNA binding 
of these species is ligand-dependent and that the nature of the central atom might be of a secondary 
significance for the binding process. The situation, however, changes for metal complex binding to synthetic 
poly(dA-dT)2 and poly(dG-dC)2 B-DNA analogues. All of the compounds show a generally higher 
preference for binding poly(dG-dC)2. In the case of poly(dA-dT)2, bis-ligand complexes show higher binding 
constants compared to those for ct-DNA, whereas tris-ligand compounds show lower Kapp values compared 
to those for ct-DNA. This suggests that a second sequence selective binding mode is available for these 
compounds in addition to the non-specific electrostatic binding. This more selective mode becomes apparent 
in binding to synthetic DNA analogues. All of the compounds exhibit slight preference for guanine-cytosine 
(GC) motifs. The apparent binding constants to synthetic DNAs for compounds 1, 9 and 10 are very similar, 
ca. 6.3 × 10
4
 M
−1
 for poly(dA-dT)2 and 6.6 × 10
4
 M
−1
 for poly(dG-dC)2. Compounds 2 and 3 show 
significantly lower apparent binding constants for both poly (dA-dT)2 and poly(dG-dC)2 DNA, suggesting 
that, in contrast to binding observed previously for ct-DNA, this binding mode is largely independent on the 
number of ligands. It is worth noting that all the tested compounds exhibit weak fluorescence at 
approximately 310 nm. Due to the characteristics of the grating monochromator, this emission was also 
visible at 620 nm (Fig. 4) and may have contributed to higher errors for some measurements as especially 
evident in the case of Co
2+
 clotri complexes (2 and 10) upon binding to poly-(dG-dC)2. 
Table 3 Apparent DNA-binding constants, Kapp (× 10
4
 M
-1
), for clotri metal complexes 1‒3, 9 and 10. Kapp values are 
the mean of two independent experiments and are expressed as mean ± SD 
 Compound ct-DNA poly(dA-dT)2 poly(dG-dC)2 
(1) [Cu(clotri)2Cl2]·5H2O 4.9 ± 0.5 6.4 ± 0.2 6.81 ± 0.09 
(2) [Co(clotri)2Cl2] 4.7 ± 0.2 5.47 ± 0.09 5.6 ±-0.7 
(3) [Zn(clotri)2Cl2] 4.9 ± 0.4 5.23 ± 0.08 5.90 ± 0.04 
(9) [Cu(clotri)3NO3]NO3·2H2O 6.2 ±0.1 6.2 ± 0.3 6.45 ±0.03 
(10) [Co(clotri)3(NO3)2]NO3 6.7 ±0.4 6.2 ± 0.2 7.0 ± 0.7 
Linear dichroism 
Linear dichroism (LD) is the difference in absorption of parallel and perpendicular linearly polarized light in 
an aligned sample.
47
 LD is an especially convenient method to probe DNA binding due to the linear nature of 
the DNA molecule. A DNA solution is aligned using the laminar flow between two concentric cylinders, one 
of which is stationary and the other of which is rotating at approximately 3000 RPM.
18,19,47
 Small molecules 
that are not aligned under these conditions are not visible in LD, and only large and linear structures such as 
DNA give rise to LD signals. Upon binding to DNA, small molecules become aligned and can give rise to 
new LD signals. Sign and magnitude of these signals often allows for determination of relative orientation of 
the binding species and thus the binding mode.
48
 An LD titration of ct-DNA and complex 
[Cu(clotri)2Cl2]·5H2O (1), and the resulting titration curve are shown in Fig. 5. Data for the compounds 2, 3, 
9 and 10 can be found in the ESI (Fig. S2–S5†). Due to weak absorbance of compounds 1–3, 9 and 10 in the 
visible part of the spectrum, no additional LD peaks were observed in this region. In the UV range, 
emergence of weak signals was observed at high compound concentrations, but these are mainly obscured by 
the strong DNA signals in those regions. To estimate the induced LD behavior of complex 
[Cu(clotri)2Cl2]·5H2O (1), a ct-DNA spectrum was overlaid on a spectrum of ct-DNA with 50 μM of 1 and 
scaled to the same intensity at 247 and 350 nm (weak or no absorbance of the compound). The differential 
spectrum was then calculated (Fig. 6, right) and a UV spectrum of 1 was overlaid for comparison. There is a 
reasonably good agreement between the shape and the positions of the main bands in both the calculated LD 
spectrum and the UV spectrum, suggesting that the new bands are indeed caused by binding of the 
compound. The presence of new LD signals demonstrates that 1 binds to the DNA in an oriented fashion 
(i.e., groove binding or intercalation). A non-specific binding mode (i.e., electrostatic interactions) would not 
result in such an alignment. The structure of the clotri complexes makes intercalation a relatively unlikely 
mode of binding, which is supported by the presence of weak positive signals in the calculated LD spectrum 
(195 nm). For intercalation, generally only negative signals would be expected, indicating that 1 is most 
likely a groove binder. Similar patterns of signals were detected in all the tested compounds (data available 
in the ESI Fig. S6–S9†), suggesting that one binding modes for all these compounds is groove binding. In all 
the titrations, the intensity of the strong negative signal from the π–π* transitions in the DNA base pairs at 
260 nm decreased in magnitude upon increasing concentrations of the compound. This phenomenon results 
from effective shortening of DNA strands due to bending, kinking, or aggregation upon binding,49 lowering 
the linearity of DNA and thus its alignment with the flow. It has previously been demonstrated that, in 
extreme cases, B-DNA strands can coil into small bundles, resulting in complete loss of negative signal at 
260 nm.
49
 CD results rule out formation of kinks as the cause of DNA shortening, leaving bending as the 
most likely cause. This is further supported by the AFM images (vide infra). To compare the relative effects 
of these complexes on DNA coiling, the titration curves were fitted to the Hill equation, and the 
concentration of ligand at which 50% loss of LD signal (Ka) was calculated (Table 4). As previously 
described, there is no obvious relation between these values and the structures of the compounds. Generally, 
the Ka value increases (activity towards DNA decreases) in the series Cu
2+
, Zn
2+
, and Co
2+
, with bis-ligand 
complexes showing smaller Ka values compared to the tris-complex of the same metal. The Ka values 
obtained for the Co
2+
 complexes (2 and 10) show significantly higher values (lower DNA activity) compared 
to others. Interestingly, in the case of 2 and 10, two distinct stages can be identified on the titration curve. At 
low concentrations, the LD signal seems to follow a typical saturation curve, with a second step at higher 
concentrations (Fig. 7). This directly supports the previous evidence of at least two possible binding modes. 
Competition between binding modes for the cobalt complexes may also explain the relatively high errors 
obtained for these compounds in the EtBr displacement assay. 
 
Fig. 5 Left: Linear dichroism (LD) spectra of 100 μM DNA with increasing concentration of 1. Right: The resulting 
titration curve at 260 nm. 
 
Fig. 6 Left: LD spectrum of ct-DNA in the presence of 1 (black line) and an overlaid LD spectrum on ct-DNA scaled to 
the same intensity (red line). Additional bands can be seen at indicated wavelengths. Right: The calculated LD spectrum 
of 1 bound to DNA (black) and an overlaid UV spectrum of 1 (red and blue, not to scale). 
Table 4 The calculated concentrations of complexes 1‒3, 9 and 10 at which 50% loss of LD signal was recorded (Ka, 
µM) 
 Compound Ka (µM) 
(1) [Cu(clotri)2Cl2]·5H2O 40 ± 1 
(2) [Co(clotri)2Cl2] 70 ± 2 
(3) [Zn(clotri)2Cl2] 51 ± 4 
(9) [Cu(clotri)3NO3]NO3·2H2O 55 ± 2 
(10) [Co(clotri)3(NO3)2]NO3 80 ± 1 
   
Fig. 7 LD signal of DNA at 260 nm with increasing 
concentration of 10 showing a two-step binding process. 
Fig. 8 CD spectra of 50 μM DNA with increasing 
concentrations of complex 3. 
Circular dichroism 
To determine if DNA binding of the clotri metal complexes causes changes in the helical structure of B-
DNA, CD spectra of DNA with increasing concentrations of compounds 1–3, 9 and 10 were acquired. As in 
the LD experiments, DNA concentration was kept constant throughout the titration by addition of equal 
volumes of double concentrated stock solution. In all cases, no significant changes were observed in a wide 
range of concentrations. Upon increasing the concentration of the compound to approximately 50 μM (1 : 1 
complex : DNA ratio) a small decrease in the CD magnitude was observed. Fig. 8 shows the CD spectra for 
[Zn(clotri)2Cl2] (3), and data for the other compounds are available in the ESI (Fig. S10–S13†). In all cases, 
only very small changes are observed in the CD spectra at the same concentration range that shows very 
large changes in the LD. Thus, binding of these complexes affects DNA alignment (bending or kinking), but 
it does not significantly affect the B-DNA helical structure. This strongly suggests that the shortening of 
DNA observed in the LD is most likely caused by bending, since kinking would be expected to 
causeconsiderable distortion that would be easily observable in CD.
50
 
Atomic force microscopy (AFM) imaging 
To understand the cause of the loss of DNA signal in the LD spectra upon metal complex binding, a series of 
tapping mode atomic force microscopy (TM-AFM) images of linearized plasmid DNA (pUC19, 2686 bp) 
were recorded with increasing concentrations of [Cu(clotri)2Cl2]·5H2O (1). The non-covalent binding of 
metal complexes causes different effects on DNA tertiary structure, including inter- and intra-molecular 
coiling.
15,49
 For both DNA alone and with low concentrations of 1 (Fig. 9a and b), the DNA strands are well 
separated with little evidence of coiling, consistent with CD and LD results. At high DNA : compound 1 
ratios (10 : 5; Fig. 9d), no linear DNA was detected on the mica surface, only various-sized aggregates large 
enough to be formed from more than one DNA strand. Several attempts were made to record an image in 
which both aggregates and linear DNA were present, and the best result is shown in Fig. 9c. The difficulty in 
recording such an image indicates the very high cooperativity of this process. At moderate concentrations of 
1, a much higher inter-connectivity between the DNA strands is observed, as well as early evidence of tight 
coiling, consistent with results obtained by other methods. At low concentrations, the interaction of 1 with 
DNA is weak and does not induce changes in the DNA tertiary structure, but at moderate and high 
concentrations, a mixture of electrostatic interactions and possibly groove binding results in accretion and 
coiling of the DNA strands into tightly wound aggregates. 
 
Fig. 9 TM-AMF images of linearized pUC19 plasmid DNA with increasing concentrations of 1. (a) DNA only, (b) 10 : 
1 DNA : 1, (c) 10 : 3 DNA : 1 and (d) 10 : 5 DNA : 1. 
Electrochemistry 
Electrochemical studies of the unbound clotri ligand show that it is redox inactive within the investigated 
window (Fig. S14A†). [Zn(clotri)2Cl2] (3) and [Zn(clotri)3NO3]NO3·5H2O (11) (cyclic voltammograms in 
Fig. S14B and S14D,† respectively) also exhibit no electrochemical activity. In contrast, similar studies of 7, 
Table 5 and Fig. S14C,† show clotri-based redox waves with an E1/2 potential of 0.806 V, indicating that 
metal coordination shifts these ligand-based potentials into the measureable electrochemical window. These 
results are in agreement with DFT frontier orbital calculations (Fig. S15†) and with previous studies of 
metal-coordinated histidine and imidazole-derived ligands.
51,52
 For all three complexes, the Zn
2+
 center is 
electrochemically inactive within the examined potential window. The cyclic voltammogram of 2 in Fig. 
S16† exhibits an anodic wave at 1.206 V due to clotri ligand oxidation, whereas anodic waves at 0.977 V 
and −0.238 V represent Co2+/3+ and Co0/2+ oxidations, respectively (Table 5). Similar redox behavior for 6 is 
observed (Fig. S17B†) and DFT frontier orbital calculations for 6 support the electrochemical assignments 
(Fig. S15†). Differential pulse voltammetry (DPV) studies confirm the presence of clotri ligand oxidation 
and reduction waves for both 2 (E1/2 = 1.111 V; Fig. S17A and S17B†) and 6, as well as unambiguously 
identifying the clotri reduction wave for complex 6 (Fig. S17C and S17D†). DPV-derived potentials are not 
included in Table 5, since they are typically shifted compared to CV potentials.
53,54
 The CV of the nitrate 
complex, [Co(clotri)3(NO3)2] (10), exhibits only a Co
2+/0
 redox couple with an E1/2 value of −0.982 V. DPV 
studies of the nitrate complex also show redox potentials for the Co
3+/2+
 couple and the clotri ligand (Fig. 
S18A and S18B†). The more positive Epa value for the Co
2+/3+
 oxidation of 2 compared to 6 indicates that 
chloride coordination stabilizes Co
3+
 over Co
2+
 compared to bromide coordination. Previous studies
51
 of 
dichloride and dibromide Co
2+
 complexes with a three-nitrogen-donor, conjugated bis(imino)pyridine ligand 
showed a similar Co
3+
 stabilization (E1/2 values of 0.153 and −0.087 V, respectively). The Cu
2+
 complex 
[Cu(clotri)2Cl2]·5H2O (1) exhibits both quasi-reversible Cu
2+/+
 and Cu
+/0
 redox couples with E1/2 values of 
−0.239 and −0.852 V, respectively (Fig. 10). The CV of 5 in Fig. 10B, also shows Cu2+/+ and Cu0/+ redox 
couples (E1/2 = −0.139 and −1.022 V, respectively) as well as clotri redox activity (E1/2 = 0.788 V; Table 5), 
despite precipitation during the experiment. DFT frontier orbital calculations for 5 support such assignments, 
Fig. S15.† The anodic wave around 0.190 V and the cathodic wave around 0.620 V may result from 
formation of an electrochemically active acetonitrile complex upon decomposition of the complex.
55
 Because 
complexes 1 and 5 precipitated during the CV experiments in acetonitrile and made the electrochemical 
waves difficult to detect, similar studies were conducted in CH2Cl2 to confirm these results (Table S1, Fig. 
S19†). [Cu(clotri)3(NO3)]NO3·2H2O (9) remained in acetonitrile solution and exhibits a strong, quasi-
reversible Cu
+/0
 reduction potential (E1/2 = −1.022) and two weaker quasi-reversible reduction potentials for 
Cu
2+/+
 and the clotri ligand (E1/2 values of −0.012 V and 0.515 V, respectively; Table 5). The Cu
2+/+
 reduction 
potential of the chloride complex is the most negative, followed by the bromide and nitrate complexes, 
indicating that the hard chloride ligands most stabilize Cu
2+
 relative to Cu
+
 and consistent with the trend 
observed for Co-clotri complexes. Based on the electrochemical potentials, the additional borderline clotri 
ligand present in nitrate complex 9 has a greater influence on Cu
2+
 stability than the hard nitrate ligand. 
Electrochemical studies of [CuCl(tptm)]
+
 and [CuBr(tptm)]
+
 (tptm = tris(2-pyridylthio)methyl) also reported 
a decrease in Cu
+/2+
 oxidation potential for analogous chloride and bromide complexes (Epa values of −0.560 
and −0.463 V, respectively).56 
Table 5 Electrochemical potentials (versus NHE) from cyclic voltammetry studies of clotri complexes 1‒2, 5‒7, 9 and 
10 in acetonitrile 
Compound Epa (V) Epc (V) ΔE (V) E1/2 (V) 
1 -0.512
d, -0.082e -1.192d, -0.379e 0.680d, 0.297e -0.852d, -0.239e 
2 -0.238
b, 0.997c, 1.206a — — — 
5 -0.479
d, 0.018e, 0.962a -1.407d, -0.297e, 0.614a 0.928d, 0.279e, 0.348a -0.943d, -0.139e, 0.788a 
6 -0.038
b, 0.648c, 0.948a -1.612b, 0.376c,0755a 1.574b, 0.272c, 0.193a -0.825b, 0.512c, 0852a 
7 1.021
a 0.591a 0.435a 0.806a 
9 -0.441
d, 0.117e, 0.693a -1.603d, -0.141e, 0.338a 1.162d, 0.258e, 0.355a -1.022d, -0.012e, 0.515a 
10 -0.296
b -1.669b 1.373b -0.982b 
aClotri ligand potentials; bCo2+/0 potentials; cCo3+/2+ potentials; dCu+/0 potentials; eCu2+/+ potentials. 
 
 
   
Fig. 10 Cyclic voltammograms vs. NHE for 1 (A), 5 (B) and 8 (C) at 1mM in CH3CN with 0.1 M TBAPF6 as the 
supporting electrolyte. 
Oxidative DNA damage 
Gel electrophoresis studies were performed on 9 to determine its ability to promote oxidative DNA damage 
caused by Cu
+
 /H2O2 (pH 7). Ascorbic acid (1.25 equiv.) was added to the Cu
2+
 complex to reduce Cu
2+
 to 
hydroxyl-radical-generating Cu
+
 (eqn (1))
57
 and ethanol (10 mM) was added as a well-studied hydroxyl 
radical scavenger to mimic the presence of organic compounds in a cellular system.
58
 The copper chloride 
and bromide complexes 1 and 5 did not have sufficient water solubility to perform these DNA damage 
studies. 
Cu
+
 + H2O2  Cu
2+
 + 
•
OH + OH
–
 (1) 
DNA damage caused by increasing concentrations of complex 9 with H2O2 is shown in Fig. 11. Lane 2 
shows that hydrogen peroxide alone does not result in DNA damage, but reducing Cu
2+
 with ascorbate to 
form Cu
+
 in the presence of H2O2 results in DNA damage (lane 3, positive control). Upon adding increasing 
concentrations of complex 9, DNA damage is significantly increased, with ∼90% DNA damage at 50 µM. 
Clotri alone does not damage DNA at these concentrations (data not shown), and uncoordinated Cu
+
 
generated from CuSO4 causes ∼90% DNA damage at only 6 µM (lane 3), indicating that 9 remains largely 
intact under DNA damage assay conditions. Fig. 12 shows a best-fit dose–response curve for DNA damage 
by 9, with the concentration required to promote 50% DNA damage (EC50) calculated as 10.47 ± 0.01 µM. 
Thus, 9 significantly promotes DNA damage, consistent with previous cytotoxicity studies.
17
 
 
Fig. 11 Gel electrophoresis image of Cu
+
-mediated DNA damage by 9 in MOPS buffer (10 mM, pH 7). Lanes: MW = 1 
kb molecular weight marker; lane 1: plasmid DNA (p); lane 2: p + H2O2; lane 3: p + ascorbate (7.5 μM) + CuSO4 (6 
μM) + H2O2 (50 µM); lanes 4–18: p + increasing compound concentration + ascorbate + H2O2: 1 (lanes 4–6), 5 (lanes 
7–9), 10 (lanes 10–12), 25 (lanes 13–15), and 50 µM (lanes 16–18) 9 respectively. 
 
Fig. 12 Best-fit dose–response curve for percent DNA damage versus concentration for 9. 
DNA-adduct formation 
Similar to cisplatin, DNA is believed to be the main target for this series of clotri coordination complexes.
17
 
For this reason, DNA from the HeLa human carcinoma cell line was isolated, and the amounts of Cu
2+
, Co
2+
, 
Zn
2+
, and Ni
2+
 associated with this DNA were determined (Table 6). Cells treated with 5 have the highest 
levels of DNA-associated metal (19.9 nmol Cu
2+
/10
6
 cells) followed by 1, 3, 2, 8, and 4 (13.4, 5.9, 5.5, 4.9 
and 3.2 nmol M
2+
/10
6
 cells, respectively). The amounts of M
2+
 found on the DNA of HeLa cells does not 
strictly correlate with the cytotoxicity or hydrophobicity (log P) of the complexes. However, it does correlate 
with the LD results where DNA association follows the decreasing order Cu
2+
 > Zn
2+
 >Co
2+
. These data are 
also broadly consistent with the results of the EtBr displacement assay, where Cu
2+
 complexes generally 
showed higher affinity for DNA than Co2+ or Zn2+. Overall, as suggested from the results presented herein, it 
is reasonable to assume that DNA is a potential target for these cytotoxic clotri-metal complexes. 
Table 6 DNA metal concentration of metal ion for 
complexes 1‒5 and 8 in HeLa human carcinoma cell line 
(nM
2+
/10
6
 cells) 
Compound 
DNA binding 
(nM M2+/106 cells) 
(1) [Cu(clotri)2Cl2]·5H2O 13.4 
(2) [Co(clotri)2Cl2] 5.5 
(3) [Zn(clotri)2Cl2] 5.9 
(4) [Ni(clotri)2Cl2]·H2O 3.2 
(5) [Cu(clotri)2Br2]·5H2O 19.9 
(8) [Ni(clotri)3Br2] 4.9 
Cytotoxicity 
The obtained results correlate well with the previously published cytotoxicity data.
17
 Cu
2+
 compounds 1 and 
9 have been shown to exhibit generally lower IC50 values in HeLa growth studies compared with Co
2+
 
complexes 2 and 10. This finding correlates well with LD data suggesting that DNA interactions might be 
the cause of these compounds’ cytotoxicity. The electrochemical results also correlate with the reported 
cytotoxicity, since Cu
2+
 complexes 1, 5, and 9 were the most cytotoxic clotri complexes,
17
 and these Cu
2+
 
complexes readily undergo reduction to Cu
+
 (Cu
2+/+
 potentials of −0.239 to −0.012 V). Cellular Cu+ is known 
to generate hydroxyl radical that causes DNA damage and death,
59
 and this reaction primarily occurs in 
biological systems if the metal redox potentials are between −0.324 to 0.460 V.60 The less electrochemically 
accessible Co
3+/2+
 potentials (0.512 V for the cobalt chloride complex 2 and only an oxidation potential of 
0.977 V for the cobalt bromide complex 6) lie outside the biological window for hydroxyl radical generation, 
so these complexes may be less likely to cause cellular damage by ROS formation. Unsurprisingly, the redox 
inactive Zn
2+
 complexes were found to be the least cytotoxic.
9
 Correlation of the cellular toxicity results with 
the electrochemical redox potentials for these complexes suggest that some of these compounds may cause 
cell death by generating ROS. Given the degree of DNA damage observed at relatively low concentrations of 
the copper complex 9, it is likely that copper-mediated oxidative DNA damage is a significant part of the 
cytotoxicity. 
Conclusions 
DNA binding behavior of selected clotrimazole complexes was investigated using CD and LD spectroscopy, 
UV melting experiments, atomic force microscopy (AFM) and an ethidium bromide (EtBr) displacement 
assay. These results strongly suggest that the compounds bind to DNA in at least two different binding 
modes depending on the concentration, sequence of the DNA, and the structure of the complex. These results 
also show the dramatic effects that binding of these complexes has on the linear structure of the DNA. In 
addition, correlation of cytotoxicity data with the electrochemical redox potentials for these complexes also 
suggests that some of these compounds may cause cell death by generating ROS. The amounts of M
2+
 found 
on the DNA of human carcinoma cells did not correlate with the cytotoxic potency or hydrophobicity (log P) 
of the complexes. Overall, our results open wide possibilities for the design of complexes with not only 
desired cytotoxic activity, but also the capability of targeting specific DNA sequences. Such structural effects 
and, specifically, the ability to control and tune them are of high importance for the design of novel 
generations of metal-based anticancer complexes. 
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